secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2023-04-06T23:59:59+00:00
Accession:  0001104659-23-042706
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Kathleen Bloch retires, stays as Interim CFO under consulting agreement through Dec 2025
--------------------------------------------------------------------------------

- Bloch retired as CFO effective March 31, 2023, but will serve as Interim CFO under a Consulting Agreement.
- Consulting rate: $335/hour, expected 20 hours/week; agreement lasts until Dec 31, 2025 unless terminated earlier.
- Awarded 20,000 stock options at $3.37/share (3/31/23 closing price) with 10-year term; existing RSUs continue vesting.
- Bloch provides customary CFO services; may be terminated by either party with 14 days' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923042706/0001104659-23-042706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465923042706/tm2311957d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-042706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer